Skip to main content

Distinguished Speaker Series | Ana Maria Cuervo, MD, PhD

-
Location
https://ucihealth.zoom.us/j/92801383742?pwd=vfI4WBKGwibdfbtyznYWvAbSg3CccO.1
Event Type

Add to Calendar: Outlook | Google | iCal

The Center for Translational Vision Research Distinguished Speaker Series, also known as "Friday Seminars" showcases innovative research across the world. The seminar series has now been expanded to include lectures by experts on topics ranging from Ophthalmology, Genetics, Biochemistry, Neurobiology, Imaging, Computational Sciences to Novel Ophthalmic Treatments.

All talks are hybrid. You can join us in person at

The Falling Leaves Foundation Building, Main Entrance Level

Conference Room (2nd Floor by signage)

847 Health Sciences Quad

You can also join us by zoom. Zoom link and information are on your right and in the calendar links above.

March 13, 2026 | Ana Maria Cuervo, MD, PhD

Selective autophagy: paving the way for healthy aging one protein at a time

 

Learn More About the Distinguished Speaker Series

Featured


Ana Maria Cuervo, MD, PhD
Ana Maria Cuervo, MD, PhD
  • Ana Maria Cuervo, MD, PhD, The Robert and Renee Belfer Chair for the Study of Neurodegenerative; Distinguished Professor, Department of Developmental and Molecular Biology; Co-director, Institute for Aging Research, Albert Einstein College of Medicine

Ana Maria Cuervo, M.D., Ph.D., is the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases and a Distinguished Professor in the Department of Developmental and Molecular Biology at the Albert Einstein College of Medicine. She also serves as Co-Director of the Institute for Aging Research. Trained as both a physician and a scientist, Dr. Cuervo’s research focuses on the cellular mechanisms that maintain protein quality control and how their decline contributes to aging and neurodegenerative disorders. Her laboratory is internationally recognized for pioneering work on autophagy, particularly chaperone-mediated autophagy (CMA), a selective pathway for the degradation of damaged or misfolded proteins. Using a multidisciplinary approach that integrates molecular biology, biochemistry, cell biology, and animal models, her team investigates how defects in intracellular degradation pathways contribute to conditions such as Parkinson’s disease and other age-related neurodegenerative disorders. Through uncovering the molecular basis of proteostasis failure, her work aims to identify novel therapeutic targets to promote healthy aging and combat neurodegeneration.